Skip to content
Cyberttak.
Healthcare· 2 min read

Causal reinforcement learning improved cognitive intervention plans for 61 patients

Researchers used AI to reduce weekly therapy time while potentially boosting memory scores in patients with mild cognitive impairment.

By CyberttakPublished · 17:42
A hand-drawn infographic describing Alzheimer's diagnostic research and care approaches
A hand-drawn infographic describing Alzheimer's diagnostic research and care approachesCredit: Photo: jurvetson / Flickr · CC BY 2.0 (cropped)

A new research study published in npj Digital Medicine demonstrates how artificial intelligence can tailor therapy for patients with mild cognitive impairment. By using a technique called causal reinforcement learning, the team created a system that automatically adjusts treatment strategies based on an individual's unique health markers.

Traditional clinical guidelines often rely on static, one-size-fits-all approaches. In this trial involving 61 participants, the AI-driven framework analyzed data including age, baseline cognitive scores, and existing health conditions to select the most effective activities for each person.

Participants engaged in three different types of activities: virtual reality Taichi, traditional offline Taichi, and computerized cognitive training exercises. The system evaluated how these activities impacted individual treatment effects and adjusted the plan accordingly.

Significant efficiency gains

The results suggest that the AI framework is more efficient than standard practices. Participants following the AI-optimized strategies saw an average improvement of 1.03 points on the Memory Guard scale. More importantly, the system achieved these results while requiring much less time, cutting weekly intervention intensity down to 15 to 90 minutes from the standard 120 to 240 minutes.

Several factors appeared to drive the model's decisions. The researchers found that a patient's diabetes status, their current age, and their initial cognitive baseline were the most significant variables in determining which treatment would work best.

However, the study also identified clear limitations. The AI-suggested interventions showed reduced benefits for older participants, those with hypertension, men, and individuals with higher levels of education. It is worth considering, how might these data-driven tools change the way clinics handle long-term care plans?

Source: npj Digital Medicine